Fresenius Medical Care AG - Ordinary Shares without par value (FMS)

Historical Holders from Q1 2014 to Q1 2025

Symbol
FMS on NYSE
CUSIP
358029106
Type / Class
Equity / Ordinary Shares without par value
Shares outstanding
293M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
34M
Holdings value
$770M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
185
Number of buys
94
Number of sells
-57
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Fresenius Medical Care AG - Ordinary Shares without par value (FMS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fresenius SE & Co. KGaA 28.6% -11.3% $2.09B -$264M 83.8M -11.2% Fresenius SE & Co. KGaA Mar 6, 2025
HARRIS ASSOCIATES L P 3.9% $292M 11.7M HARRIS ASSOCIATES L P Dec 31, 2024

Institutional Holders of Fresenius Medical Care AG - Ordinary Shares without par value (FMS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 346K $8.61M +$675K $24.90 32
2024 Q4 34M $770M +$5.18M $22.64 185
2024 Q3 33.5M $713M +$47M $21.30 162
2024 Q2 31.3M $598M -$36.5M $19.09 164
2024 Q1 33.2M $640M -$1.23M $19.28 167
2023 Q4 33.1M $689M +$509K $20.83 156
2023 Q3 32M $689M -$25.4M $21.54 141
2023 Q2 34.1M $816M -$114M $23.93 138
2023 Q1 38.9M $828M -$107M $21.26 144
2022 Q4 44.1M $721M +$191M $16.34 146
2022 Q3 32.5M $457M -$40.2M $14.04 128
2022 Q2 32.2M $803M +$53.2M $24.94 149
2022 Q1 30.6M $1.03B +$97.8M $33.68 170
2021 Q4 27.7M $899M +$54.2M $32.46 166
2021 Q3 25.9M $905M +$191M $34.97 151
2021 Q2 20.4M $846M +$44.5M $41.57 168
2021 Q1 19.3M $714M +$311M $36.88 162
2020 Q4 10.4M $434M +$61.9M $41.56 163
2020 Q3 9.06M $385M +$321K $42.48 172
2020 Q2 9.27M $401M +$18M $43.28 166
2020 Q1 8.9M $292M -$31.8M $32.80 155
2019 Q4 7.71M $284M +$32.1M $36.83 149
2019 Q3 8.23M $276M -$7.93M $33.59 145
2019 Q2 8.86M $348M -$264K $39.28 155
2019 Q1 8.85M $359M -$93.9M $40.53 170
2018 Q4 11.2M $363M -$140M $32.39 170
2018 Q3 14.6M $753M -$4.11M $51.42 204
2018 Q2 15.1M $760M -$7.64M $50.35 212
2018 Q1 15.3M $780M +$23.8M $51.08 220
2017 Q4 14.8M $777M -$202M $52.55 210
2017 Q3 18.6M $911M +$126M $48.89 201
2017 Q2 15.4M $742M -$31.3M $48.33 182
2017 Q1 16.5M $696M +$30.9M $42.13 180
2016 Q4 15.7M $664M +$4.83M $42.21 180
2016 Q3 15.5M $679M +$53.8M $43.77 175
2016 Q2 14.3M $622M +$22M $43.57 166
2016 Q1 13.8M $607M +$162M $44.08 166
2015 Q4 10M $419M -$44.4M $41.84 142
2015 Q3 11.2M $437M +$1.74M $39.01 132
2015 Q2 10.9M $455M -$11.9M $41.59 137
2015 Q1 11.8M $488M -$13M $41.45 135
2014 Q4 12.2M $453M -$28.4M $37.14 135
2014 Q3 12.9M $448M -$19.2M $34.70 123
2014 Q2 13.5M $452M -$28.8M $33.49 129
2014 Q1 14.3M $500M -$53.9M $34.85 124